Welcome! We regret to inform you that the Injury Board National News Desk has been discontinued. Feel free to browse around and enjoy our previously published articles, or visit The Injury Blog Network for the latest in personal injury news.

News tagged with 'Antidepressants and Other Psychiatric Drugs'

Posted by Jane Akre
December 22, 2007 8:39 PM

    Zyprexa is an antipsychotic drug effectively given to treat millions of adults with schizophrenia or bipolar disorder.  It may now receive FDA approval for use in kids despite severe side effects including diabetes and weight gain. 

Posted by Staff Writer
July 02, 2007 4:32 PM

Lilly Settles Zyprexa Claims Eli Lilly has agreed to pay up to half a billion dollars in order to settle around 18,000 claims directed against the international pharmaceutical concern. These injured parties claimed they had developed diabetes or suffered a stroke while taking Lilly’s number one atypical

Posted by Staff Writer
July 02, 2007 10:24 AM

Zyprexa-Related Strokes The drug manufacturer Eli Lilly & Co. issued a warning in 2004 that its atypical antipsychotic drug Zyprexa may increase the risk of stroke and death in elderly patients when Zyprexa is used to treat aggression from dementia caused by Alzheimer’s disease. Lilly issued the

Posted by Staff Writer
June 29, 2007 8:53 AM

Lilly Settles Zyprexa Claims Updated June 2007- Eli Lilly established this month a class settlement fund worth nearly $700 million for the nearly 8,000 plaintiffs who would agree to settle their claims against the drugmaker for their use of the prescription drug Zyprexa. Zyprexa, also known as olanzapine

Posted by Staff Writer
June 10, 2003 12:00 AM

The United Kingdom Department of Health's Medicines and Healthcare Products Regulatory Agency advised physicians Tuesday to immediately halt prescribing the antidepressant Seroxat to patients under 18 due to the medication's link to suicidal behavior in children. According to the British government, a clinical trial i

Posted by Staff Writer
March 07, 2003 12:00 AM

Consumer interest group Public Citizen called on the U.S. Food and Drug Administration (FDA) Thursday to immediately ban the antidepressant medication Serzone, citing its link to life-threatening liver toxicity that has led to at least 11 deaths in the United States. In January, Serzone maker Bristol-Myers Squibb st

Posted by Staff Writer
January 14, 2003 12:00 AM

According to a new study published in the January 13th issue of the medical journal Archives of Internal Medicine, patients taking serotonin reuptake inhibitors (SSRIs) in combination with nonsteroidal anti-inflammatory drugs (NSAIDs) are 12 times more likely to suffer from upper gastrointestinal bleeding than those wh

Posted by Staff Writer
January 09, 2003 12:00 AM

Britain's Committee on Safety of Medicines has ordered a review panel to evaluate the safety of selective serotonin reuptake inhibitors (SSRIs) due to claims that the medications cause suicidal feelings. SSRIs, a group of antidepressants that include GlaxoSmithKline's Seroxat, sold in the United States as Paxil, have

Posted by Staff Writer
January 09, 2003 12:00 AM

Serzone withdrawal: Pharmaceutical maker Bristol-Myers Squibb announced this week that it will stop selling the antidepressant medication Dutonin in Europe because of its link to 25 reports of liver failure and 18 deaths. Sold in the United States under the brand name Serzone, Dutonin has been linked to severe liver p

Posted by Staff Writer
January 03, 2003 12:00 AM

The Food and Drug Administration has approved new uses for the antidepressant Prozac (fluoxetine) to treat children and adolescents seven to 17 years of age for depression (major depressive disorder) and obsessive compulsive disorder (OCD). This is the first approval of one of the newer types of antidepressants (select

Posted by Staff Writer
December 27, 2002 12:00 AM

The Food and Drug Administration (FDA) has approved a new use for the schizophrenia drug, Clozaril: to reduce the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. Clozaril was approved in 1989 for treatment of schizophrenia in patients who do not respond to other available

Posted by Staff Writer
December 19, 2002 12:00 AM

According to a new study on the safety of antipsychotic medications, the use of dopamine antagonists is associated with an increased risk of breast cancer. Published in this month's issue of Archives of General Psychiatry, the study, conducted by researchers from Brigham and Women's Hospital in Boston, analyzed more t

Posted by Staff Writer
December 03, 2002 12:00 AM

A Pennsylvania family has settled a two-year-old negligence lawsuit with pharmaceutical maker Eli Lilly and Co., the maker of the antidepressant medication Prozac. In their suit, Diane and Melvin Cassidy of Monroeville alleged Prozac caused suicidal thoughts and led Diane Cassidy to slit her wrists and overdose on a p

Posted by Staff Writer
November 21, 2002 12:00 AM

The Netherlands Medicine Assessments Board (CBG) announced Wednesday that it will begin an investigation of the anti-depressant drug nefazodone, sold in the Netherlands under the brand name Dutonin and in the United States as Serzone, after receiving 26 reports of liver failure and several reports of deaths worldwide.

Posted by Staff Writer
November 19, 2002 12:00 AM

At the request of the U.S. Food and Drug Administration, the pharmaceutical company Pfizer has issued an important drug warning letter announcing the addition of new information to the CONTRAINDICATIONS and PRECAUTIONS sections of the Zoloft label, contraindicating the concomitant use of pimozide (a tranquilizer) with

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact InjuryBoard.com

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes